IART Stock Recent News

IART LATEST HEADLINES

IART Stock News Image - GlobeNewsWire

PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company's first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. EDT.

GlobeNewsWire 2024 Apr 18
IART Stock News Image - Zacks Investment Research

Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.

Zacks Investment Research 2024 Apr 09
IART Stock News Image - Zacks Investment Research

Integra (IART) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research 2024 Mar 29
IART Stock News Image - Zacks Investment Research

Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.

Zacks Investment Research 2024 Mar 12
IART Stock News Image - Zacks Investment Research

Integra's (IART) Q4 revenues are impacted by the decline in the Tissue Technologies segment.

Zacks Investment Research 2024 Feb 29
IART Stock News Image - Zacks Investment Research

The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research 2024 Feb 28
IART Stock News Image - Zacks Investment Research

Integra LifeSciences (IART) came out with quarterly earnings of $0.89 per share, missing the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.94 per share a year ago.

Zacks Investment Research 2024 Feb 28
IART Stock News Image - Zacks Investment Research

Besides Wall Street's top -and-bottom-line estimates for Integra (IART), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

Zacks Investment Research 2024 Feb 26
IART Stock News Image - Zacks Investment Research

Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research 2024 Feb 21
IART Stock News Image - GlobeNewsWire

PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.

GlobeNewsWire 2024 Feb 07
10 of 50